Difficulty: Medium
Average Score: 83%
Practice
During counseling with Om Khamis, a pregnant hypertensive patient. You advised her to avoid the following antihypertensive that may cause renal damage in the fetus:
Correct answer
A
Rationale
In the case of a pregnant hypertensive patient like Om Khamis, it is crucial to consider the safety of antihypertensive medications for both the mother and the fetus. The correct answer, A) Captopril, is known to be contraindicated during pregnancy due to its potential to cause renal damage in the fetus. Captopril is an ACE inhibitor that has been associated with fetal renal malformations and even death when used during pregnancy. Therefore, advising Om Khamis to avoid Captopril is essential to protect the health of her unborn child.
Now, let's analyze why the other options are incorrect:
B) Diazoxide is a vasodilator used to treat severe hypertension and is generally considered safe during pregnancy.
C) Fenoldopam is a selective dopamine receptor agonist used for the treatment of severe hypertension and is not known to cause renal damage in the fetus.
D) Guanethidine is an older antihypertensive agent that has largely been replaced by newer, safer medications. While it may have side effects, renal damage in the fetus is not a known concern.
In an educational context, this question highlights the importance of considering the safety profiles of medications, especially in vulnerable populations like pregnant women. Understanding the risks and benefits of different antihypertensive agents is essential for healthcare providers to make informed decisions and provide optimal care to their patients. It also emphasizes the need for thorough counseling and personalized treatment plans to ensure the well-being of both the mother and the fetus.
Now, let's analyze why the other options are incorrect:
B) Diazoxide is a vasodilator used to treat severe hypertension and is generally considered safe during pregnancy.
C) Fenoldopam is a selective dopamine receptor agonist used for the treatment of severe hypertension and is not known to cause renal damage in the fetus.
D) Guanethidine is an older antihypertensive agent that has largely been replaced by newer, safer medications. While it may have side effects, renal damage in the fetus is not a known concern.
In an educational context, this question highlights the importance of considering the safety profiles of medications, especially in vulnerable populations like pregnant women. Understanding the risks and benefits of different antihypertensive agents is essential for healthcare providers to make informed decisions and provide optimal care to their patients. It also emphasizes the need for thorough counseling and personalized treatment plans to ensure the well-being of both the mother and the fetus.